Cargando…
Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development
Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic cont...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901233/ https://www.ncbi.nlm.nih.gov/pubmed/24957774 http://dx.doi.org/10.3390/metabo2041031 |
_version_ | 1782300823058907136 |
---|---|
author | Wurtele, Eve Syrkin Chappell, Joe Daniel Jones, A. Celiz, Mary Dawn Ransom, Nick Hur, Manhoi Rizshsky, Ludmila Crispin, Matthew Dixon, Philip Liu, Jia Widrlechner, Mark P. Nikolau, Basil J. |
author_facet | Wurtele, Eve Syrkin Chappell, Joe Daniel Jones, A. Celiz, Mary Dawn Ransom, Nick Hur, Manhoi Rizshsky, Ludmila Crispin, Matthew Dixon, Philip Liu, Jia Widrlechner, Mark P. Nikolau, Basil J. |
author_sort | Wurtele, Eve Syrkin |
collection | PubMed |
description | Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic context. Here, we describe a database and platform for storing, visualizing and statistically analyzing metabolomics data from fourteen medicinal plant species. The metabolomes and associated transcriptomes (RNAseq) for each plant species, gathered from up to twenty tissue/organ samples that have experienced varied growth conditions and developmental histories, were analyzed in parallel. Three case studies illustrate different ways that the data can be integrally used to generate testable hypotheses concerning the biochemistry, phylogeny and natural product diversity of medicinal plants. Deep metabolomics analysis of Camptotheca acuminata exemplifies how such data can be used to inform metabolic understanding of natural product chemical diversity and begin to formulate hypotheses about their biogenesis. Metabolomics data from Prunella vulgaris, a species that contains a wide range ofantioxidant, antiviral, tumoricidal and anti-inflammatory constituents, provide a case study of obtaining biosystematic and developmental fingerprint information from metabolite accumulation data in a little studied species. Digitalis purpurea, well known as a source of cardiac glycosides, is used to illustrate how integrating metabolomics and transcriptomics data can lead to identification of candidate genes encoding biosynthetic enzymes in the cardiac glycoside pathway. Medicinal Plant Metabolomics Resource (MPM) [1] provides a framework for generating experimentally testable hypotheses about the metabolic networks that lead to the generation of specialized compounds, identifying genes that control their biosynthesis and establishing a basis for modeling metabolism in less studied species. The database is publicly available and can be used by researchers in medicine and plant biology. |
format | Online Article Text |
id | pubmed-3901233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-39012332014-05-27 Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development Wurtele, Eve Syrkin Chappell, Joe Daniel Jones, A. Celiz, Mary Dawn Ransom, Nick Hur, Manhoi Rizshsky, Ludmila Crispin, Matthew Dixon, Philip Liu, Jia Widrlechner, Mark P. Nikolau, Basil J. Metabolites Article Specialized compounds from photosynthetic organisms serve as rich resources for drug development. From aspirin to atropine, plant-derived natural products have had a profound impact on human health. Technological advances provide new opportunities to access these natural products in a metabolic context. Here, we describe a database and platform for storing, visualizing and statistically analyzing metabolomics data from fourteen medicinal plant species. The metabolomes and associated transcriptomes (RNAseq) for each plant species, gathered from up to twenty tissue/organ samples that have experienced varied growth conditions and developmental histories, were analyzed in parallel. Three case studies illustrate different ways that the data can be integrally used to generate testable hypotheses concerning the biochemistry, phylogeny and natural product diversity of medicinal plants. Deep metabolomics analysis of Camptotheca acuminata exemplifies how such data can be used to inform metabolic understanding of natural product chemical diversity and begin to formulate hypotheses about their biogenesis. Metabolomics data from Prunella vulgaris, a species that contains a wide range ofantioxidant, antiviral, tumoricidal and anti-inflammatory constituents, provide a case study of obtaining biosystematic and developmental fingerprint information from metabolite accumulation data in a little studied species. Digitalis purpurea, well known as a source of cardiac glycosides, is used to illustrate how integrating metabolomics and transcriptomics data can lead to identification of candidate genes encoding biosynthetic enzymes in the cardiac glycoside pathway. Medicinal Plant Metabolomics Resource (MPM) [1] provides a framework for generating experimentally testable hypotheses about the metabolic networks that lead to the generation of specialized compounds, identifying genes that control their biosynthesis and establishing a basis for modeling metabolism in less studied species. The database is publicly available and can be used by researchers in medicine and plant biology. MDPI 2012-11-21 /pmc/articles/PMC3901233/ /pubmed/24957774 http://dx.doi.org/10.3390/metabo2041031 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Wurtele, Eve Syrkin Chappell, Joe Daniel Jones, A. Celiz, Mary Dawn Ransom, Nick Hur, Manhoi Rizshsky, Ludmila Crispin, Matthew Dixon, Philip Liu, Jia Widrlechner, Mark P. Nikolau, Basil J. Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title | Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title_full | Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title_fullStr | Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title_full_unstemmed | Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title_short | Medicinal Plants: A Public Resource for Metabolomics and Hypothesis Development |
title_sort | medicinal plants: a public resource for metabolomics and hypothesis development |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901233/ https://www.ncbi.nlm.nih.gov/pubmed/24957774 http://dx.doi.org/10.3390/metabo2041031 |
work_keys_str_mv | AT wurteleevesyrkin medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT chappelljoe medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT danieljonesa medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT celizmarydawn medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT ransomnick medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT hurmanhoi medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT rizshskyludmila medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT crispinmatthew medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT dixonphilip medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT liujia medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT widrlechnermarkp medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment AT nikolaubasilj medicinalplantsapublicresourceformetabolomicsandhypothesisdevelopment |